每年專案
個人檔案
學歷
- 2010-2013 國立臺灣大學生醫電子與資訊學研究所博士
- 1981-1997 長庚醫學院醫學系醫學士
經歷
- 2023.02- 臺北醫學大學醫學系內科學科教授
- 2023.02- 臺北醫學大學醫學院人工智慧醫療碩士在職專班教授
- 2021.08- 臺北市立萬芳醫院內科部胸腔內科主任
- 2020.02-2023.01 臺北醫學大學醫學系內科學科副教授
- 2020.01-2023.01 臺北醫學大學醫學院人工智慧醫療碩士在職專班副教授
- 2019.08-2020.01 臺北醫學大學醫學院人工智慧醫療碩士在職專班助理教授
- 2019.05-2019.07 臺北醫學大學醫學院人工智慧醫療碩士在職專班籌備處助理教授
- 2014- 臺北市立萬芳醫院胸腔內科主治醫師
- 2014.11-2020.01 臺北醫學大學醫學系內科學科助理教授
- 2014.11-2013.12 臺北市立萬芳醫院結核病中心主任
- 2004-2013 臺北慈濟醫院主治醫師
- 2003.07-2004.10 亞東醫院主治醫師
獎項
- 2019 臺北醫學大學附屬醫院研究計畫獎
- 2014 最佳審查委員 Pharmacoepidemiology and Drug Safety.
研究興趣
- 結核病
- 慢性阻塞性肺病
- 健康資料庫
- 重症加護醫學
指紋
- 1 類似的個人檔案
過去五年中的合作和熱門研究領域
專案
- 5 已完成
-
The prognostic value of NT-proBNP in 28-day mortality and post-discharge survival in pneumonia: a retrospective cohort study from Taiwan
Nguyen, V. D., Lin, H. C., Lee, W. C., Ju, K. S., Dai, J. E., Hsieh, P. N., Chen, C. Y. & Lee, C. H., 2025, 於: Expert Review of Respiratory Medicine. 19, 3, p. 257-267 11 p.研究成果: 雜誌貢獻 › 文章 › 同行評審
-
Two-drug versus three-drug regimens for treating Mycobacterium avium complex infection: A systematic review and meta-analysis
Nguyen, V. D., Duong, H., Lee, M. C., Chen, J. H., Huang, W. C., Chen, H. E., Lin, J. C., Wang, J. Y. & Lee, C. H., 5月 2025, 於: Journal of Infection and Public Health. 18, 5, 102711.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取 -
Unveiling unique effector function-related bulk antibody profiles in long-term hemodialysis patients following COVID-19 mRNA booster vaccination
Chou, C. Y., Cheng, C. Y., Lee, C. H., Kuro-O, M., Chen, T. H., Wang, S. Y., Chuang, Y. K., Yang, Y. J., Lin, Y. H. & Tsai, I. L., 2月 2025, 於: Journal of Microbiology, Immunology and Infection. 58, 1, p. 27-37 11 p.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取 -
A Phase 3, Randomized, Controlled Trial Evaluating the Efficacy and Safety of Ropeginterferon Alfa-2b in Patients with Moderate COVID-19
Liu, W. D., Feng, P. H., Cheng, C. Y., Chou, C. L., Lee, C. H., Lu, M. C., Liu, P. Y., Lee, M. H., Liao, C. H., Chen, M. C., Chen, C. P., Hsu, S. F., Tzeng, Y. T., Lin, Y. C., Ou, T. Y., Qin, A., Tsai, C. Y., Shih, W. J., Lee, K. Y. & Sheng, W. H., 2024, (接受/付印) 於: Infectious Diseases and Therapy. 13, 7, p. 1575-1588 14 p.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取 -
Clofazimine and QT prolongation in the treatment of rifampicin-resistant tuberculosis: Findings of aDSM in Taiwan
Lin, C. J., Chen, J. H., Chien, S. T., Huang, Y. W., Lin, C. B., Lee, J. J., Lee, C. H., Yu, M. C. & Chiang, C. Y., 10月 2024, 於: Journal of Microbiology, Immunology and Infection. 57, 5, p. 791-800 10 p.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取
資料集
-
Additional file 1: of Treatment delay and fatal outcomes of pulmonary tuberculosis in advanced age: a retrospective nationwide cohort study
Lee, C.-H. (Contributor), Wang, J.-Y. (Contributor), Lin, H.-C. (Contributor), Lin, P.-Y. (Contributor), Chang, J.-H. (Contributor), Suk, C.-W. (Contributor), Lee, L.-N. (Contributor), Lan, C.-C. (Contributor) & Bai, K.-J. (Contributor), Unknown Publisher, 6月 24 2017
DOI: 10.6084/m9.figshare.c.3810436_d1.v1, https://springernature.figshare.com/articles/journal_contribution/Additional_file_1_of_Treatment_delay_and_fatal_outcomes_of_pulmonary_tuberculosis_in_advanced_age_a_retrospective_nationwide_cohort_study/5143333/1
資料集: Dataset
-
Treatment delay and fatal outcomes of pulmonary tuberculosis in advanced age: a retrospective nationwide cohort study
Lee, C.-H. (Creator), Wang, J.-Y. (Contributor), Lin, H.-C. (Contributor), Lin, P.-Y. (Contributor), Chang, J.-H. (Contributor), Suk, C.-W. (Contributor), Lee, L.-N. (Creator), Lan, C.-C. (Contributor) & Bai, K.-J. (Contributor), Figshare, 2017
DOI: 10.6084/m9.figshare.c.3810436.v1, https://figshare.com/collections/Treatment_delay_and_fatal_outcomes_of_pulmonary_tuberculosis_in_advanced_age_a_retrospective_nationwide_cohort_study/3810436/1
資料集: Dataset
-
Additional file 4: of Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in chemoprevention of hepatocellular carcinoma: a nationwide high-risk cohort study
Ho, C.-M. (Contributor), Lee, C.-H. (Contributor), Lee, M.-C. (Contributor), Zhang, J.-F. (Contributor), Wang, J.-Y. (Contributor), Hu, R.-H. (Contributor) & Lee, P.-H. (Contributor), Unknown Publisher, 4月 10 2018
DOI: 10.6084/m9.figshare.6119192.v1, https://springernature.figshare.com/articles/Additional_file_4_of_Comparative_effectiveness_of_angiotensin-converting_enzyme_inhibitors_and_angiotensin_II_receptor_blockers_in_chemoprevention_of_hepatocellular_carcinoma_a_nationwide_high-risk_cohort_study/6119192/1
資料集: Dataset
-
Additional file 3: of Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in chemoprevention of hepatocellular carcinoma: a nationwide high-risk cohort study
Ho, C.-M. (Contributor), Lee, C.-H. (Contributor), Lee, M.-C. (Contributor), Zhang, J.-F. (Contributor), Wang, J.-Y. (Contributor), Hu, R.-H. (Contributor) & Lee, P.-H. (Contributor), Unknown Publisher, 4月 10 2018
DOI: 10.6084/m9.figshare.6119174.v1, https://springernature.figshare.com/articles/Additional_file_3_of_Comparative_effectiveness_of_angiotensin-converting_enzyme_inhibitors_and_angiotensin_II_receptor_blockers_in_chemoprevention_of_hepatocellular_carcinoma_a_nationwide_high-risk_cohort_study/6119174/1
資料集: Dataset
-
Additional file 6: of Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in chemoprevention of hepatocellular carcinoma: a nationwide high-risk cohort study
Ho, C.-M. (Contributor), Lee, C.-H. (Contributor), Lee, M.-C. (Contributor), Zhang, J.-F. (Contributor), Wang, J.-Y. (Contributor), Hu, R.-H. (Contributor) & Lee, P.-H. (Contributor), Unknown Publisher, 4月 10 2018
DOI: 10.6084/m9.figshare.6119222.v1, https://springernature.figshare.com/articles/Additional_file_6_of_Comparative_effectiveness_of_angiotensin-converting_enzyme_inhibitors_and_angiotensin_II_receptor_blockers_in_chemoprevention_of_hepatocellular_carcinoma_a_nationwide_high-risk_cohort_study/6119222/1
資料集: Dataset